TSKU
TSKU (tsukushi, small leucine rich proteoglycan) is a secreted protein that contributes to development, wound healing and cholesterol homeostasis by acting on several signalling pathways. It is also known as E2IG4, TSK and LRRC54. Browse Assay Genie's current range of TSKU research reagents below, or read on for the biology behind the target.
TSKU is a secreted protein that acts through multiple signalling pathways. It is a Wnt signalling inhibitor: it competes with WNT2B for binding to the Wnt receptor FZD4, and in this way represses WNT2B-dependent development of the peripheral eye. It also controls TGFB1 signalling, which links it to the hair cycle. In wound healing it inhibits TGFB1 secretion from macrophages. This prevents myofibroblast differentiation and keeps inflammatory cells quiescent.
The TSKU protein has several roles in development. It is required for the anterior commissure of the brain, where it inhibits neurite outgrowth, and for terminal differentiation of hippocampal neural stem cells. It affects bone elongation and bone mass by modulating growth plate chondrocyte function and overall body size. It is also needed for inner ear development through stereocilia formation in inner hair cells. NCBI Gene predicts that it binds transforming growth factor beta. It also predicts involvement in ciliary body morphogenesis, telencephalon development and negative regulation of Wnt signalling. The protein is predicted to sit in the interstitial matrix.
TSKU also has a role in metabolism. It reduces circulating high-density lipoprotein cholesterol, lowers cholesterol efflux capacity and decreases cholesterol-to-bile acid conversion in the liver. In brown fat, one study showed that it negatively regulates sympathetic innervation and so reduces energy expenditure. Another study found no effect on brown fat thermogenic capacity, body weight gain or glucose homeostasis. The TSKU gene has been listed under the names tsukushin and leucine rich repeat containing 54, and its mouse and rat orthologs are both called Tsku.
TSKU inhibits Wnt signalling by competing with WNT2B for binding to FZD4, making it a useful tool for studying Wnt regulation in development.
TSKU controls TGFB1 signalling and limits its secretion from macrophages, which prevents myofibroblast differentiation during wound healing.
TSKU is required for the anterior commissure, hippocampal neural stem cell differentiation and inner ear stereocilia formation.
TSKU reduces circulating HDL cholesterol and cholesterol efflux capacity, and its role in brown fat energy expenditure is still debated.
TSKU is a secreted protein that inhibits Wnt signalling by competing with WNT2B for binding to FZD4. It also regulates TGFB1 signalling. It contributes to brain, eye, inner ear and bone development, wound healing and cholesterol homeostasis. Check the datasheet of any product for its validated reactivity.
TSKU is the approved symbol for tsukushi, small leucine rich proteoglycan. Aliases and previous symbols include E2IG4, TSK and LRRC54. Earlier names include tsukushin and leucine rich repeat containing 54. UniProt lists the protein simply as Tsukushi.
Yes. Both mouse and rat have an ortholog named Tsku. Much of what is known about the protein's roles in eye, brain, ear, bone and lipid biology comes from functional studies of the protein, and its actions on Wnt and TGF-β signalling appear in the UniProt annotation.
Wnt pathway components, TGF-β signalling proteins and other regulators of development and cholesterol homeostasis with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WUA8; product specifications from Assay Genie datasheets.